AI-generated analysis. Always verify with the original filing.
Ekso Bionics entered into a Contribution and Exchange Agreement to acquire Applied Digital Cloud Corporation in exchange for 138,216,820 shares of common stock, resulting in Contributor owning ~97% of the combined company post-closing, with name change to ChronoScale Corporation. The filing also discloses preliminary Q4 2025 revenue of $3.0-3.1M (down from $5.1M YoY) and cash of $1.2M.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. Contribution and Exchange Agreement On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso
shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by referen
Unregistered Sales of Equity Securities. The information set forth under Item 1.01 of this Current Report on Form 8-K relating to the Contribution and Exchange
. Item 5.01 Changes in Control of Registrant. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this I
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On February 14, 2026, the Board approved the 2026 Omnibu
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 14, 2026, the Board adopted an amendment (“Amendment No. 1”) to the Compan
Financial Statements and Exhibits EXHIBIT INDEX Exhibit No. Description 3.1 Amendment No. 1 to the Amended and Restated Bylaws of Ekso Bionics Holdings, Inc. 3.
| Metric | Value | Basis |
|---|---|---|
| Total revenue | $3.05 | |
| Gross margin | 52.5% |